Cargando…
Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study
BACKGROUND: Kidney transplantation (KTx) is a strong trigger for the development of either recurrent or de novo atypical haemolytic uraemic syndrome (aHUS). According to previous studies, eculizumab (ECU) is effective for prophylaxis and for treatment of recurrence. METHODS: We evaluated the experie...
Autores principales: | Portoles, José, Huerta, Ana, Arjona, Emilia, Gavela, Eva, Agüera, Marisa, Jiménez, Carlos, Cavero, Teresa, Marrero, Domingo, Rodríguez de Córdoba, Santiago, Diekmann, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023214/ https://www.ncbi.nlm.nih.gov/pubmed/33841863 http://dx.doi.org/10.1093/ckj/sfaa096 |
Ejemplares similares
-
Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017) -
Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
por: Gómez Delgado, Irene, et al.
Publicado: (2020) -
Early treatment with eculizumab in atypical haemolytic uraemic syndrome
por: Garjau, Maria, et al.
Publicado: (2012) -
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021) -
Recent advances in diagnosis and treatment of atypical haemolytic uraemic syndrome
por: Bolton-Maggs, Paula HB
Publicado: (2010)